BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12802717)

  • 1. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.
    Herrera-Arellano A; Jiménez-Ferrer E; Vega-Pimentel AM; Martínez-Rivera Mde L; Hernández-Hernández M; Zamilpa A; Tortoriello J
    Planta Med; 2004 Jun; 70(6):483-8. PubMed ID: 15241887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
    Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effectiveness of Ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial.
    Romero-Cerecero O; Zamilpa A; Jiménez-Ferrer E; Tortoriello J
    J Altern Complement Med; 2012 Jun; 18(6):607-11. PubMed ID: 22784348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind clinical trial for evaluating the effectiveness and tolerability of Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. A comparative study with ciclopirox.
    Romero-Cerecero O; Zamilpa A; Jiménez-Ferrer JE; Rojas-Bribiesca G; Román-Ramos R; Tortoriello J
    Planta Med; 2008 Oct; 74(12):1430-5. PubMed ID: 18671197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
    Herrera-Arellano A; López-Villegas EO; Rodríguez-Tovar AV; Zamilpa A; Jiménez-Ferrer E; Tortoriello J; Martínez-Rivera MA
    Afr J Tradit Complement Altern Med; 2013; 10(3):410-7. PubMed ID: 24146467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solanum chrysotrichum (Schldl.) a plant used in Mexico for the treatment of skin mycosis.
    Lozoya X; Navarro V; García M; Zurita M
    J Ethnopharmacol; 1992 Apr; 36(2):127-32. PubMed ID: 1608268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis.
    Romero-Cerecero O; Román-Ramos R; Zamilpa A; Jiménez-Ferrer JE; Rojas-Bribiesca G; Tortoriello J
    J Ethnopharmacol; 2009 Oct; 126(1):74-8. PubMed ID: 19683043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE; Vlahovic TC
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis.
    Elewski BE; Jones T; Zaias N
    Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
    Hoharitanon S; Chaichalotornkul J; Sindhupak W
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S167-72. PubMed ID: 16623023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
    López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
    Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.